Qualigen Therapeutics Inc. (AIXC)
NASDAQ · Healthcare
Qualigen Therapeutics Inc. Revenue 2020–2022
Qualigen Therapeutics Inc. annual/quarterly revenue history and growth rate from 2020 to 2023. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Qualigen Therapeutics Inc. revenue for the quarter ending June 30, 2023 was 1.6 M, a 13.74% increase year-over-year.
- Qualigen Therapeutics Inc. revenue for the twelve months ending June 30, 2023 was 6.1 M, a 24.75% increase year-over-year.
- Qualigen Therapeutics Inc. annual revenue for 2022 was 5.0 M, a 11.85% decrease from 2021.
- Qualigen Therapeutics Inc. annual revenue for 2021 was 5.7 M, a 31.29% increase from 2020.
- Qualigen Therapeutics Inc. annual revenue for 2020 was 4.3 M, a 22.52% decrease from 2020.
- Qualigen Therapeutics Inc. annual revenue for 2020 was 5.6 M.
Revenue
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Qualigen Therapeutics Inc. Revenue — FAQ
Qualigen Therapeutics Inc. (AIXC) revenue over the last 4 years — annual and quarterly figures with year-over-year growth and charts.
What is Qualigen Therapeutics Inc.'s revenue?
Qualigen Therapeutics Inc. (AIXC) reported revenue of $5M for fiscal 2022.
Where can I see AIXC's revenue history?
The chart and table above show Qualigen Therapeutics Inc.'s revenue by year and by quarter, including the growth rate.